Association Between Serum SFRP1 Levels and Coronary Artery Calcification in Stage 5D Chronic Kidney Disease

H Chen1, J Jin, M Cheng

  • 1Hebei Clinical Research Center for Chronic Kidney Disease, Hebei Key Laboratory of Vascular Calcification in Kidney Disease, Department of Nephrology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China.

Insights

Elevated serum Secreted Frizzled-Related Protein 1 (SFRP1) levels are linked to coronary artery calcification (CAC) in patients with Stage 5D chronic kidney disease (CKD) on maintenance hemodialysis (MHD). SFRP1 may serve as a biomarker for identifying at-risk individuals.

Area of Science:

  • Nephrology
  • Cardiology
  • Biochemistry

Background:

  • Patients with Stage 5D chronic kidney disease (CKD) undergoing maintenance hemodialysis (MHD) have a high prevalence of cardiovascular disease, particularly coronary artery calcification (CAC).
  • Secreted Frizzled-Related Protein 1 (SFRP1) is a protein that plays a role in Wnt signaling, which is implicated in vascular calcification.
  • The association between SFRP1 levels and CAC in this specific patient population remains under-investigated.

Purpose of the Study:

  • To investigate the association between serum SFRP1 levels and the presence and severity of CAC in patients with Stage 5D CKD on MHD.
  • To identify potential biomarkers for predicting CAC in this high-risk group.

Main Methods:

  • A case-control study was conducted with 76 patients undergoing MHD.
  • Patients were stratified into non-calcified, low-score calcification, and high-score calcification groups based on Coronary Artery Calcium Scores (CACS).
  • Serum SFRP1 and various biochemical parameters were measured; correlation and multivariate linear regression analyses were performed.

Main Results:

  • Coronary artery calcification (CAC) was present in 60.5% of the study population.
  • Serum SFRP1 concentrations were significantly higher in patients with high-score CAC compared to other groups (p < 0.01).
  • SFRP1 and phosphorus levels were identified as independent risk factors for CAC (p < 0.05), with SFRP1 demonstrating a high predictive value (AUC = 0.898).

Conclusions:

  • Elevated serum SFRP1 levels are significantly associated with an increased likelihood and severity of CAC in patients with Stage 5D CKD on MHD.
  • SFRP1 emerges as a potential novel biomarker for early detection and risk stratification of CAC in this vulnerable patient cohort.
  • Further research is warranted to explore the therapeutic implications of targeting SFRP1 in CKD-related cardiovascular complications.

Related Concept Videos

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area. This equation is...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate01:25

Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate

The glomerular filtration rate (GFR) is a critical indicator of kidney health, reflecting how well the kidneys filter blood. Changes in GFR can signal potential kidney impairment, necessitating accurate measurement methods to monitor kidney function effectively.Various molecules can serve as markers for GFR measurement, with the ideal marker meeting several specific criteria. It must freely filter at the glomerulus, avoid reabsorption or secretion by the renal tubules, remain unmetabolized, not...